204 related articles for article (PubMed ID: 32138840)
1. Low Stromal Mast Cell Density in Canine Mammary Gland Tumours Predicts a Poor Prognosis.
Ariyarathna H; Thomson N; Aberdein D; Munday JS
J Comp Pathol; 2020 Feb; 175():29-38. PubMed ID: 32138840
[TBL] [Abstract][Full Text] [Related]
2. Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas.
Sakalauskaitė S; Riškevičienė V; Šengaut J; Juodžiukynienė N
Acta Vet Scand; 2022 Jun; 64(1):14. PubMed ID: 35761297
[TBL] [Abstract][Full Text] [Related]
3. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
[TBL] [Abstract][Full Text] [Related]
4. Mast cells in canine cutaneous hemangioma, hemangiosarcoma and mammary tumors.
Woldemeskel M; Rajeev S
Vet Res Commun; 2010 Feb; 34(2):153-60. PubMed ID: 20127412
[TBL] [Abstract][Full Text] [Related]
5. Canine transmissible venereal tumour: assessment of mast cell numbers as indicators of the growth phase.
Mukaratirwa S; Chiwome T; Chitanga S; Bhebhe E
Vet Res Commun; 2006 Aug; 30(6):613-21. PubMed ID: 16838203
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours.
Santos A; Lopes C; Marques RM; Amorim I; Ribeiro J; Frias C; Vicente C; Gärtner F; de Matos A
Vet J; 2011 Jul; 189(1):43-8. PubMed ID: 20598596
[TBL] [Abstract][Full Text] [Related]
7. Tryptase-positive mast cells correlate with angiogenesis in canine mammary carcinoma.
Im KS; Kim JH; Yhee JY; Yu CH; Kim NH; Nho WG; Sur JH
J Comp Pathol; 2011; 144(2-3):157-63. PubMed ID: 20934709
[TBL] [Abstract][Full Text] [Related]
8. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.
Santos AA; Lopes CC; Ribeiro JR; Martins LR; Santos JC; Amorim IF; Gärtner F; Matos AJ
BMC Vet Res; 2013 Jan; 9():1. PubMed ID: 23289974
[TBL] [Abstract][Full Text] [Related]
10. Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components.
Amini P; Nassiri S; Malbon A; Markkanen E
Sci Rep; 2020 Mar; 10(1):5506. PubMed ID: 32218455
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
12. A statistical assessment of the biological relationship between simultaneous canine mammary tumours.
Gunnes G; Borge KS; Lingaas F
Vet Comp Oncol; 2017 Jun; 15(2):355-365. PubMed ID: 26452754
[TBL] [Abstract][Full Text] [Related]
13. Chemokine gene expression influences metastasis and survival time of female dogs with mammary carcinoma.
Ariyarathna H; Thomson N; Aberdein D; Munday JS
Vet Immunol Immunopathol; 2020 Sep; 227():110075. PubMed ID: 32590239
[TBL] [Abstract][Full Text] [Related]
14. Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours.
Canadas-Sousa A; Santos M; Medeiros R; Dias-Pereira P
J Comp Pathol; 2019 Oct; 172():72-79. PubMed ID: 31690419
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
[TBL] [Abstract][Full Text] [Related]
16. Tumour-associated macrophages: Relation with progression and invasiveness, and assessment of M1/M2 macrophages in canine mammary tumours.
Monteiro LN; Rodrigues MA; Gomes DA; Salgado BS; Cassali GD
Vet J; 2018 Apr; 234():119-125. PubMed ID: 29680383
[TBL] [Abstract][Full Text] [Related]
17. Solitary and multiple simultaneous malignant epithelial mammary tumours in dogs: An explorative retrospective study.
Pecile A; Groppetti D; Ferrari R; Grieco V; Giudice C; Spediacci C; Stefanello D; Boracchi P
Res Vet Sci; 2021 Mar; 135():153-161. PubMed ID: 33524825
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Histological Grade and Histopathological Appearance in Canine Mammary Carcinomas.
Tanaka Y; Koyama K; Horiuchi N; Watanabe K; Kobayashi Y
J Comp Pathol; 2020 Aug; 179():59-64. PubMed ID: 32958149
[TBL] [Abstract][Full Text] [Related]
19. Plasma interleukin-1α and interleukin-8 in female dogs with non-metastatic and metastatic malignant mammary gland tumours.
Szczubiał M; Łopuszyński W; Dąbrowski R; Bochniarz M; Brodzki P
Pol J Vet Sci; 2022 Jun; 25(2):317-324. PubMed ID: 35861995
[TBL] [Abstract][Full Text] [Related]
20. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
